Related Experiment Video
Updated: Nov 3, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association Between Serum Elabela Levels and Chronic Totally Occlusion in Patients with Stable Angina Pectoris
1Departamento de Cardiologia, Adıyaman University Training and Research Hospital, Adıyaman - Turquia.
Insights
Serum Elabela levels are lower in patients with chronic total occlusion (CTO) and correlate with poor collateral development. Lower Elabela indicates a higher risk of CTO and weaker collateral circulation.
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Interventional Cardiology
Background:
- Elabela's beneficial cardiovascular effects are documented.
- Chronic total occlusion (CTO) poses significant cardiovascular risks.
- Collateral circulation is crucial for managing ischemic heart disease.
Purpose of the Study:
- To compare serum Elabela levels in CTO patients versus controls.
- To investigate the correlation between Elabela levels and collateral development in CTO patients.
Main Methods:
- Cross-sectional and prospective study design.
- Inclusion of 50 CTO patients and 50 control subjects with normal coronary arteries.
- Measurement of serum Elabela, NT-proBNP, and troponin levels; assessment of collateral development using Rentrop classification.
Main Results:
- Demographics and routine labs were similar between groups.
- CTO patients exhibited lower mean Elabela levels but higher NT-proBNP and troponin compared to controls.
- Elabela levels were independently predictive of CTO and positively correlated with good collateral development (Rentrop class 2-3).
Conclusions:
- Reduced serum Elabela levels are associated with CTO.
- Elabela levels correlate with the extent of coronary collateral development.
- Elabela may serve as a potential biomarker for CTO and collateralization.
Background:
The beneficial effects of Elabela on the cardiovascular system have been shown in studies.
Objective:
To compare serum Elabela levels of chronic total occlusion (CTO) patients with control patients with normal coronary arteries, and to investigate whether there is a correlation with collateral development.
Methods:
The study was planned cross-sectionally and prospectively. Fifty patients (28.0% female, mean age 61.6±7.3years) with CTO in at least one coronary vessel and 50 patients (38% female, mean age 60,7±6.38 years) with normal coronary arteries were included in the study. Patients in the CTO group were divided into two groups as Rentrop 0-1, those with weak collateral development, and Rentrop 2-3 with good collateral development. In addition to the age, sex, demographic characteristics and routine laboratory tests of the patients, Elabela levels were measured.
Results:
Demographic characteristics and laboratory values were similar in both groups. While the mean NT-proBNP and troponin were higher in the CTO group, the Elabela mean was lower (p <0.05 for all). In the multivariate regression analysis, NT-proBNP and Elabela levels were found to be independent predictors for CTO. Also, Elabela level was found to be statistically higher in Rentrop class 2-3 patients compared to Rentrop class 0-1 patients (p<0.05).
Conclusion:
In our study, we showed that the average Elabela level was low in CTO patients compared to normal patients. In addition, we found the level of Elabela to be lower in patients with weak collateral development compared to patients with good collateral development. (Arq Bras Cardiol. 2021; [online].ahead print, PP.0-0).
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina II: Classification
Acute Coronary Syndrome I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

